Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript August 1, 2024

Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.00501 EPS, expectations were $0.01.

Operator: Good day, ladies and gentlemen. Welcome to Aurinia Pharmaceuticals Second Quarter 2024 Earnings Call. [Operator Instructions]. As a reminder, this conference is being recorded. I would like to turn the conference over to your host, Andrea Christopher, Head of Corporate...